Surpassing San Diego: An Interview With UK Biotech's New Chair Osbourn
This article was originally published in Scrip
Executive Summary
Dr Jane Osbourn, vice president of R&D at AstraZeneca PLC's MedImmune business, takes over as chair of the UK BioIndustry Association from Jan. 1, 2016. Stepping into the role vacated by biotech veteran Dr Edward Hodgkin after two years serving on the board, she faces the challenge of delivering on an ambitious 10-year vision for the UK biotech sector laid out by the BIA in April 2015.